ENTERA BIO IS-0000769 Cash Flow-to-Debt Ratio
ENTERA BIO IS-0000769 cash flow-to-debt ratio. ENTERA BIO IS-0000769 (5DT) has a Cash Flow-to-Debt Ratio of -0.28x as of June 2026, meaning its operating cash flow of €-3.46 Million could theoretically repay 0% of its total liabilities (€12.21 Million) in one year. See financial flexibility index of ENTERA BIO IS-0000769 to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of ENTERA BIO IS-0000769 (2021–2025)
Cash flow-to-debt ratio of ENTERA BIO IS-0000769 from 2021 to 2025. Historical debt coverage capacity for ENTERA BIO IS-0000769 across 5 annual periods. Also explore net asset momentum of ENTERA BIO IS-0000769 to track the company's year-over-year net asset growth rate.
ENTERA BIO IS-0000769 Cash Flow-to-Debt Ratio by Year (2021–2025)
ENTERA BIO IS-0000769 cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for ENTERA BIO IS-0000769. For the full cash flow conversion analysis, see ENTERA BIO IS-0000769 operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.55x | €-7.37 Million | €2.89 Million | ▲ +51.0% |
| 2024 | -5.20x | €-6.82 Million | €1.31 Million | ▲ +1.8% |
| 2023 | -5.30x | €-7.31 Million | €1.38 Million | ▲ +41.8% |
| 2022 | -9.10x | €-12.50 Million | €1.37 Million | ▼ -243.7% |
| 2021 | -2.65x | €-9.06 Million | €3.42 Million | — |